Sumitomo Chemical Company, Limited (SMM.F)
Chart Events
Performance Outlook
| Previous Close | 3.5000 |
| Open | 3.4000 |
| Bid | 3.0600 x 545600 |
| Ask | 3.3600 x 532400 |
| Day's Range | 3.2000 - 3.4000 |
| 52 Week Range | 3.2000 - 4.4800 |
| Volume | |
| Avg. Volume | 4 |
| Market Cap | 5.529B |
| Beta (5Y Monthly) | 0.93 |
| PE Ratio (TTM) | 556.67 |
| EPS (TTM) | 0.0060 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.18 (5.17%) |
| Ex-Dividend Date | Mar 30, 2023 |
| 1y Target Est | N/A |
- American City Business Journals
Peninsula drug company Myovant to go private in $1.7 billion buyout
A company led by former Genentech Inc. president Myrtle Potter will buy part of Brisbane-based drug maker Myovant Sciences Ltd. and take the company private in a $1.7 billion deal. The buyout by New York-based Sumitovant Biopharma Ltd. and parent company Sumitomo Pharma Co. Ltd. of Japan puts the value of Myovant (NYSE: MYOV) at $2.9 billion. Myovant, which in six years built to nearly 600 employees and developed two drugs approved for three conditions in women's health and prostate cancer, earlier this month rejected a buyout offer by the group of companies controlled by Sumitomo Chemical Co. Ltd. At that time, Myovant's board said that $22.75-per-share bid for the 48% stake the group didn't already own "significantly" undervalued Myovant.
- American City Business Journals
'Significantly' undervalued $1 billion offer for Peninsula biopharma sends stock soaring
The company, which has three approved products for women's health and prostate cancer, said the offer undervalues it.
- PR Newswire
Ginkgo Bioworks Announces Latest Collaboration for Beauty and Personal Care Industry with Sumitomo Chemical
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the launch of a new cell programming project as part of a broader collaboration with Sumitomo Chemical Co., Ltd (TSE:4005), one of Japan's leading chemical companies. Through this partnership, Sumitomo Chemical will leverage Ginkgo's extensive codebase and expertise in organism engineering to produce molecules in a sustainable fashion that are used in products across a broad range of industries. Th
